Dover Corp
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|YR | LOCK|$jh<@ | LOCK|k%!mLlg |
Dover Earnings: Full-Year Guidance Disappoints Us, but This Setback Is Transitory
Narrow-moat-rated Dover's full-year guidance underwhelmed us, but we maintain our $174 fair value estimate. However, Dover did slightly beat our third-quarter expectations, both for revenue and EPS. We should have anticipated the reduced full-year sales guidance given weak book-to-bills in parts of Dover's business and the implied greater-than-typical seasonal leap in the fourth quarter. That's particularly true in both the climate and pumps portions of Dover's business. We were also anticipating a recovery in Dover's biopharma business this year that simply didn't materialize.
